Prevention of intrauterine adhesions

Czech version

Authors: M. Emingr; M. Halaj; M. Malčák; J. Hanáček
Authors‘ workplace: Ústav pro péči o matku a dítě, Praha
Published in: Ceska Gynekol 2023; 88(3): 210-213
Category:
doi: https://doi.org/10.48095/cccg2023210

Overview

Intrauterine adhesions are a serious complication that occurs after intrauterine procedures, most often in connection with pregnancy. Manifestations such as amenorrhea, pelvic pain, and infertility for a woman, especially in reproductive age, are serious and together with intrauterine adhesions we call them Asherman’s syndrome. Primary prevention after intrauterine procedures is important. Published studies show that the use of hyaluronic acid gel, especially after abortions, leads to the prevention of moderate and severe intrauterine adhesions and also increases the pregnancy rate.

Keywords:

prevention – hyaluronic acid – intrauterine adhesions – Asherman – abortions

Sources

1. Schenker JG, Margalioth EJ. Intrauterine adhesions: an updated appraisal. Fertil Steril 1982; 37 (5): 593–610. doi: 10.1016/s0015-0282 (16) 46268-0.

2. Vancaillie TG, Garad R. Asherman’s syndrome. Aust Nurs J 2013; 20 (8): 34–36.

3. Yamamoto N, Takeuchi R, Izuchi D et al. Hysteroscopic adhesiolysis for patients with Asherman’s syndrome: menstrual and fertility outcomes. Reprod Med Biol 2013; 12 (4): 159–166. doi: 10.1007/s12522-013-0149-x.

4. Salazar CA, Isaacson K, Morris S. A comprehensive review of Asherman’s syndrome: causes, symptoms and treatment options. Curr Opin Obstet Gynecol 2017; 29 (4): 249–256. doi: 10.1097/GCO.0000000000000378.

5. Han Q, Du Y. Advances in the application of biomimetic endometrium interfaces for uterine bioengineering in female infertility. Front Bioeng Biotechnol 2020; 8: 153. doi: 10.3389/fbioe.2020.00153.

6. The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Müllerian anomalies and intrauterine adhesions. Fertil Steril 1988; 49 (6): 944–955. doi: 10.1016/s0015-0282 (16) 599 42-7.

7. Hooker AB, Lemmers M, Thurkow AL et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update 2014; 20 (2): 262–278. doi: 10.1093/humupd/dmt045.

8. Yu D, Wong YM, Cheong Y et al. Asherman syndrome – one century later. Fertil Steril 2008; 89 (4): 759–779. doi: 10.1016/j.fertnstert.2008. 02.096.

9. Kim MJ, Lee Y, Lee C et al. Accuracy of three dimensional ultrasound and treatment outcomes of intrauterine adhesion in infertile women. Taiwan J Obstet Gynecol 2015; 54 (6): 737–741. doi: 10.1016/j.tjog.2015.10.011.

10. Bosteels J, Weyers S, D‘Hooghe TM et al. Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility. Cochrane Database Syst Rev 2017; 11 (11): CD011110. doi: 10.1002/14651858.CD011110.pub3.

11. Salwowska NM, Bebenek KA, Żądło DA et al. Physiochemical properties and application of hyaluronic acid: a systematic review. J Cosmet Dermatol 2016; 15 (4): 520–526. doi: 10.1111/jocd.12237.

12. Liu C, Lu Q, Zhang Z et al. HyaRegen Adhesion Study Group. A randomized controlled trial on the efficacy and safety of a new crosslinked hyaluronan gel in reducing adhesions after gynecologic laparoscopic surgeries. J Minim Invasive Gynecol 2015; 22 (5): 853–863. doi: 10.1016/j.jmig.2015.04.011.

13. Fuchs N, Smorgick N, Ben Ami I et al. Intercoat (Oxiplex/AP Gel) for preventing intrauterine adhesions after operative hysteroscopy for suspected retained products of conception: double-blind, prospective, randomized pilot study. J Minim Invasive Gynecol 2014; 21 (1): 126–130. doi: 10.1016/j.jmig.2013.07. 019.

14. Hooker AB, de Leeuw R, van de Ven PM et al. Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: short-term outcomes of a multicenter, prospective randomized controlled trial. Fertil Steril 2017; 107 (5): 1223. e3–1231.e3. doi: 10.1016/j.ertnstert.2017.02.113.

15. Acunzo G, Guida M, Pellicano M et al. Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study. Hum Reprod 2003; 18 (9): 1918–1921. doi: 10.1093/humrep/deg368.

16. Li X, Wu L, Zhou Y et al. New crosslinked hyaluronan gel for the prevention of intrauterine adhesions after dilation and curettage in patients with delayed miscarriage: a prospective, multicenter, randomized, controlled trial. J Minim Invasive Gynecol 2019; 26 (1): 94–99. doi: 10.1016/j.jmig.2018.03.032.

17. Guida M, Acunzo G, Di Spiezio Sardo A et al. Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: a prospective, randomized, controlled study. Hum Reprod 2004; 19 (6): 1461–1464. doi: 10.1093/humrep/deh238.

18. Xiao S, Wan Y, Zou F et al. Prevention of intrauterine adhesion with auto-crosslinked hyaluronic acid gel: a prospective, randomized, controlled clinical study. Zhonghua Fu Chan Ke Za Zhi 2015; 50 (1): 32–36.

19. Tsapanos VS, Stathopoulou LP, Papathanassopoulou VS et al. The role of Seprafilm bioresorbable membrane in the prevention and therapy of endometrial synechiae. J Biomed Mater Res 2002; 63 (1): 10–14. doi: 10.1002/jbm.10040.

20. Zheng F, Xin X, He F et al. Meta-analysis on the use of hyaluronic acid gel to prevent intrauterine adhesion after intrauterine operations. Exp Ther Med 2020; 19 (4): 2672–2678. doi: 10.3892/etm.2020.8483.

21. Hooker AB, de Leeuw RA, van de Ven PM et al. Pregnancy and neonatal outcomes 42 months after application of hyaluronic acid gel following dilation and curettage for miscarriage in women who have experienced at least one previous curettage: follow-up of a randomized controlled trial. Fertil Steril 2020; 114 (3): 601–609. doi: 10.1016/j.fertnstert.2020.04.021.

22. Xu W, Zhang Y, Yang Y et al. Effect of early second-look hysteroscopy on reproductive outcomes after hysteroscopic adhesiolysis in patients with intrauterine adhesion, a retrospective study in China. Int J Surg 2018; 50: 49–54. doi: 10.1016/j.ijsu.2017.11.040.

23. Wei M, Lin X, Zhou F et al. Safety and acceptability of intrauterine balloon stent used in uterine after hysteroscopic adhesiolysis to prevent adhesion reformation. Zhonghua Yi Xue Za Zhi 2014; 94 (39): 3095–3097.

24. Abu Rafea BF, Vilos GA, Oraif AM et al. Fertility and pregnancy outcomes following resectoscopic septum division with and without intrauterine balloon stenting: a randomized pilot study. Ann Saudi Med 2013; 33 (1): 34–39. doi: 10.5144/0256-4947.2013.34.

25. Krajčovičová R, Hudeček R, Ventruba P et al. The role of hyaluronan in Asherman‘s syndrome therapy. J Gynecol Surg 2015; 31: 250–254. doi: 10.1089/gyn.2014.0129.

26. Unanyan A, Pivazyan L, Krylova E et al. Comparison of effectiveness of hyaluronan gel, intrauterine device and their combination for prevention adhesions in patients after intrauterine surgery: systematic review and meta-analysis. J Gynecol Obstet Hum Reprod 2022; 51 (4): 102334. doi: 10.1016/j.jogoh.2022.102334.

27. Zeng Y, Ran W, Lan Let al. Auto-cross linked hyaluronan gel enhances effects of hysteroscopic adhesiolysis treatment in patients with moderate to severe intrauterine adhesions. Adv Bioeng Biomed Sci Res 2022; 5 (1): 23–28.

28. Lee WL, Liu CH, Cheng M et al. Focus on the primary prevention of intrauterine adhesions: current concept and vision. Int J Mol Sci 2021; 22 (10): 5175. doi: 10.3390/ijms22105175.